Association of neoepitopes with disease severity and respiratory hospitalization in patients with IPF
J. Oldham (Sacramento, California, United States of America), J. Todd (Durham, North Carolina, United States of America), M. Neely (Durham, North Carolina, United States of America), H. Mulder (Durham, North Carolina, United States of America), R. Overton (Durham, North Carolina, United States of America), H. Kim (Minneapolis, Minnesota, United States of America), M. Gulati (New Haven, Connecticut, United States of America), T. Leonard (Ridgefield, Connecticut, United States of America), S. Palmer (Durham, North Carolina, United States of America), I. Noth (Charlottesville, Virginia, United States of America), C. Hesslinger (Biberach, Germany)
Source: Virtual Congress 2020 – Promising biomarkers for idiopathic interstitial pneumonia
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Oldham (Sacramento, California, United States of America), J. Todd (Durham, North Carolina, United States of America), M. Neely (Durham, North Carolina, United States of America), H. Mulder (Durham, North Carolina, United States of America), R. Overton (Durham, North Carolina, United States of America), H. Kim (Minneapolis, Minnesota, United States of America), M. Gulati (New Haven, Connecticut, United States of America), T. Leonard (Ridgefield, Connecticut, United States of America), S. Palmer (Durham, North Carolina, United States of America), I. Noth (Charlottesville, Virginia, United States of America), C. Hesslinger (Biberach, Germany). Association of neoepitopes with disease severity and respiratory hospitalization in patients with IPF. 5188
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: